SB 56 Kentucky Senate · 2022 Regular Session

AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

Summary

Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist.

Bill status signed all 5 stages cleared

Introduction

Jan 2022

Committee Review

Mar 2022

Senate Passage

Mar 2022

House Passage

Mar 2022

Signed into Law

Apr 2022

Introduced Jan 6, 2022 Signed Apr 8, 2022

Floor votes · Senate Mar 30, 2022

How they voted

91–0

Passed

Total votes 91

Mar 30, 2022

D Democratic24

24 Yea

100% Yea

R Republican67

67 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 8, 2022

Signed into law

signed by Governor (Acts Ch. 154)

upper

Mar 30, 2022

Upper · Passed

enrolled, signed by President of the Senate

upper

Mar 30, 2022

Lower · Passed

enrolled, signed by Speaker of the House

lower

Mar 30, 2022

Upper · Passed

3rd reading, passed 98-0

upper

Mar 17, 2022

Upper · Passed

reported favorably, 1st reading, to Calendar

upper

Mar 9, 2022

Committee

to Health & Family Services (H)

lower

Jan 20, 2022

Committee

to Committee on Committees (H)

lower

Jan 19, 2022

Upper · Passed

3rd reading, passed 35-0 with Floor Amendment (1)

upper

Jan 18, 2022

Introduced

floor amendment (1) filed

upper

Jan 18, 2022

Upper · Passed

passed over and retained in the Orders of the Day

upper

Jan 12, 2022

Upper · Passed

reported favorably, 1st reading, to Calendar

upper

Jan 10, 2022

Committee

to Health & Welfare (S)

upper

Jan 6, 2022

Committee

to Committee on Committees (S)

upper

Jan 6, 2022

Introduced

introduced in Senate

upper

1 primary · 0 co-sponsors